4Anderson H,Lund B,Bach F,et al.Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer,a phase Ⅱ study[J].Clin Oncel,1994,12 (8):1821-1 826.
5Noble S,Fanlds D.Manegement of advanced non-small-cell lung cancer:the potential role of gemcitabine[J].Health Outcomes,1999,5(3):167.
6Pasquini E,Tassinari D,Niconlini M.Gemcitabin in advanced NSCLC of elderly:A phase Ⅱ Study[J].Ann Oncol,(Suppl 4):A154-157.
二级参考文献40
1[1]Larry WH,George BB,Stan J,et al.Evaluation of the antitumor activity of gemcitabine[J].Cancer Res,1990,50(14) :4417-4422.
2[2]James LA,Ralf G,Earle AW,et al.A Phase Ⅰ clinical,plasma and cellular parmacology study of gemcitabine[ J].J Clin Oncol,1991,9(3) :491-498.
3[3]Boudewijn JM,Braakhuis GA,Jan BV,et al.Preclinical in vivo activity gemcitabine against human head and neck cancer [ J].Cancer Res,1991,51(1) :211-214 .
4[4]James LA.Phase I studies with the novel nucleoside analog gemcitabine[ J].Semin Oncol,1996 10(Suppl 23 ): ,25-31.
5[5]Anderson H,Lund B,Bach F,et al.Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase Ⅱ study[J].J Clin Oncol ,1994,12(9): 1821-1826.
6[6]Paymond PA,Werner RB,Geoffvey F,et al.Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase Ⅱ study[ J ].J Clin Oncol,1994,12(8): 1535-1540.
7[7]Gatzemeier R,Shepherd FA,Chevalier TL,et al.Activity of gemcitabine in patients with non-small-cell lung cancer[ J ].Eur J Cancer,1996,32 ( 1 ): 243 -248.
8[8]Fukuoka M,Takada M,Yokoyama A,et al.Phase Ⅱ study of gemcitabine for non-small-cell lung cancer in Japan [ J ] .Semin Oncol,1998,25 ( Suppl 7 ): 42-46.
9[9]Crino L,Scagliotti G,Marangolo M,et al.Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase Ⅱ trail[J].J Clin Oncol ,1997,15(1):297-303.
10[10]Lucio C,Anna MM,Giorgio VS,et al.Gemcitabine as second-line trentment for relapsing or refractory advanced non-small-cell lung cancer:a phase Ⅱ trail[J].Semin Oncol,1998,25(Suppl 9):23-26.
